Vanda Pharmaceuticals
VNDA

Vanda Pharmaceuticals (VNDA) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$20.00 from $21.00Aug 10, 2026
B. Riley SecuritiesMaintainedBuy$12.00 from $17.00Aug 10, 2026
HC Wainwright & Co.MaintainedBuy$21.00 from $24.00May 11, 2026
Truist SecuritiesInitiated CoverageBuy$18.00Mar 5, 2026
HC Wainwright & Co.MaintainedBuy$24.00 from $22.00Feb 23, 2026
HC Wainwright & Co.MaintainedBuy$22.00 from $20.00Jan 5, 2026
JefferiesMaintainedHold$7.50 from $5.00Dec 31, 2025
B. Riley SecuritiesMaintainedBuy$14.00 from $11.00Dec 31, 2025
HC Wainwright & Co.MaintainedBuy$20.00Nov 19, 2025
B. Riley SecuritiesInitiated CoverageBuy$11.00Nov 5, 2025
Cantor FitzgeraldMaintainedOverweight$11.00 from $13.00Oct 30, 2025
HC Wainwright & Co.MaintainedBuy$20.00Aug 21, 2025
Cantor FitzgeraldInitiated CoverageOverweight$13.00May 14, 2025
HC Wainwright & Co.MaintainedBuy$20.00May 7, 2025
HC Wainwright & Co.MaintainedBuy$20.00Apr 1, 2025
HC Wainwright & Co.MaintainedBuy$20.00 from $18.00Feb 18, 2025
HC Wainwright & Co.MaintainedBuy$18.00Feb 4, 2025
HC Wainwright & Co.MaintainedBuy$18.00Jan 28, 2025
HC Wainwright & Co.MaintainedBuy$18.00Jan 21, 2025
HC Wainwright & Co.MaintainedBuy$18.00Dec 23, 2024

Frequently asked questions

  • What is the latest analyst rating on VNDA?

    On Aug 10, 2026, HC Wainwright & Co. maintained Vanda Pharmaceuticals at Buy with a price target of $20.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.